New antibiotic gepotidacin shows promise as an effective oral treatment for drug-resistant gonorrhea, offering a more convenient alternative to the current standard injection.
OpenAI launches cheaper, more efficient GPT-4.1 models, outperforming previous versions and driving AI-related token price increases.
Goldman Sachs reports surging Q1 profits driven by trading surge amid market volatility from Trump's tariffs.
New antibiotic gepotidacin shows promise as an effective oral treatment for drug-resistant gonorrhea, offering a more convenient alternative to the current standard injection.
OpenAI launches cheaper, more efficient GPT-4.1 models, outperforming previous versions and driving AI-related token price increases.
Goldman Sachs reports surging Q1 profits driven by trading surge amid market volatility from Trump's tariffs.